Aino F. Jonasson

Huddinge, AB 14152, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Topical reinforcement of the cervical mucus barrier to sperm.

Topical reinforcement of the cervical mucus barrier to sperm.

Journal: Science translational medicine

Published: November 30, 2022

An Open, Uncontrolled Pilot Study on 12-Week Use of VagiVital for Treatment of Vulvovaginal Atrophy in Breast Cancer Patients Undergoing Adjuvant Aromatase-Inhibitor Therapy.

An Open, Uncontrolled Pilot Study on 12-Week Use of VagiVital for Treatment of Vulvovaginal Atrophy in Breast Cancer Patients Undergoing Adjuvant Aromatase-Inhibitor Therapy.

Journal: Medical devices (Auckland, N.Z.)

Published: February 06, 2021

A Vaginal Inlay for Reduction of Stress Urinary Incontinence: Outcome of a Randomized Clinical Trial and Four User Acceptance Studies.

A Vaginal Inlay for Reduction of Stress Urinary Incontinence: Outcome of a Randomized Clinical Trial and Four User Acceptance Studies.

Journal: Advances in urology

Published: August 18, 2020

The cytokine profile of menstrual blood.

The cytokine profile of menstrual blood.

Journal: Acta obstetricia et gynecologica Scandinavica

Published: January 13, 2020

Correction to: Defined serum- and xeno-free cryopreservation of mesenchymal stem cells.

Correction to: Defined serum- and xeno-free cryopreservation of mesenchymal stem cells.

Journal: Cell and tissue banking

Published: April 07, 2019

Population Pharmacokinetic Analysis of Vaginally and Intravenously Administered Oxytocin in Postmenopausal Women.

Population Pharmacokinetic Analysis of Vaginally and Intravenously Administered Oxytocin in Postmenopausal Women.

Journal: Journal of clinical pharmacology

Published: April 07, 2017

Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)-A randomized controlled trial.

Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)-A randomized controlled trial.

Journal: Psychoneuroendocrinology

Published: November 15, 2016

Annual direct and indirect costs attributable to nocturia in Germany, Sweden, and the UK.

Annual direct and indirect costs attributable to nocturia in Germany, Sweden, and the UK.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: April 18, 2016

Oxytocin improves cytological and histological profiles of vaginal atrophy in postmenopausal women.

Oxytocin improves cytological and histological profiles of vaginal atrophy in postmenopausal women.

Journal: Post reproductive health

Published: February 18, 2016

Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.

Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.

Journal: Post reproductive health

Published: May 22, 2015

Nocturia--an underdiagnosed and often untreated public disease

Nocturia--an underdiagnosed and often untreated public disease

Journal: Lakartidningen

Published: September 16, 2014

Defined serum- and xeno-free cryopreservation of mesenchymal stem cells.

Defined serum- and xeno-free cryopreservation of mesenchymal stem cells.

Journal: Cell and tissue banking

Published: May 12, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026